Deals · DeepTech
Vienna's SOMAREALITY raises over €3M Series A for real-time cognitive monitoring
Hardware-agnostic eye-tracking software that reads cognitive states — attention, fatigue, cognitive load — from eye movements in real time.
“With our presence in B2B and the trust put in us by our clients and partners, we've proven that cognitive insights based on eye tracking is here to stay. Now, with persisting interest in personalised health and renewed interest in wearable eye tracking technology, we're bringing our scientific underpinning to B2C.”
Vienna-based SOMAREALITY, which builds eye-tracking software to measure cognitive states in real time, has secured more than €3 million in an oversubscribed Series A. The round was led by Catalyst Romania — its 13th investment from Fund II — with existing backers MT-Lab, RDY Ventures, Moondust Ventures and Gateway Ventures participating.
Reading the mind from the eyes
Founded in 2020 by Adrian Brodesser and Michel Varilek, SOMAREALITY analyses eye movements that are closely linked to cognitive functions such as attention, memory and decision-making. Patterns like saccades and fixations, the company says, reveal how information is being processed and which cognitive tasks are engaged — yielding real-time readings of cognitive load, conscious perception, attention and fatigue onset.
The software is deliberately hardware-agnostic and built as a "white-box" approach, producing personalised insights after only a few seconds of data. It is offered both as a local integration and as a web service, and the company is now working on on-chip deployment so it can run on any pair of wearable glasses. Its flagship product, Cognitive Load, has been followed by modules for perception, attention and fatigue, with overall cognitive performance and health next.
From the cockpit to the consumer
This is not a pre-revenue story. SOMAREALITY reports more than €2 million in B2B revenue since taking its first biomarker to market in 2024, and says it more than doubled revenue in 2025, helped by partnerships with eye-tracking hardware makers and software distributors. Its traction sits in high-risk industries — aviation, healthcare, professional sports and research.
Co-founder Adrian Brodesser frames the round as a bridge to a wider market: having proven the B2B case, the company wants to bring "cognitive insights based on eye tracking" to consumers. Alin Stanciu, Partner at Catalyst Romania, said the team is "rethinking entire industries" by turning eye-tracking data into a read on how people think. The capital goes to three places: expanding B2B segments, funding longitudinal studies of cognitive health over time, and a brand extension into B2C.
Sources
Threaded to this story
DeepTech ·
Bristol's Astral Systems raises €26M Series A to turn fusion reactors into a medical-isotope business
€26M · Series A
DeepTech ·
Pixel-Flo raises €6.1M Seed to make microLED displays manufacturable at mass-market cost
€6.1M · Seed
DeepTech ·
alqem raises €8 million to map the materials universe and build rare-earth-free magnets
€8M · pre-Seed
Every European round, in your inbox by 8am.
The day's seed and Series A rounds across France and Europe — threaded, sourced, and read in two minutes. Free.